Ketamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketamine Hydrochloride Injection (injection) from Pfizer Inc. with status No longer listed by FDA. The shortage was first posted on Nov 7, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Pfizer Inc.
- Package NDC
- 0409-0040-10
- Dosage Form
- Injection
- Presentation
- Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)
- Initial Posting
- Nov 7, 2025